Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-03-02 @ 5:53 PM
Study NCT ID:
NCT03159702
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-24
First Post:
2017-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
Sponsor:
Medical College of Wisconsin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-17
First Submit QC Date:
None
Study First Post Date:
2017-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-10-22
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-22
Last Update Post Date:
2025-01-24
Last Update Post Date Type:
ACTUAL